Annual Current Liabilities
$7.69 M
+$4.60 M+148.63%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual total current liabilities is $7.69 million, with the most recent change of +$4.60 million (+148.63%) on December 31, 2023.
- During the last 3 years, VRPX annual current liabilities has risen by +$4.03 million (+110.22%).
- VRPX annual current liabilities is now at all-time high.
Performance
VRPX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.36 M
-$3.03 M-56.25%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly total current liabilities is $2.36 million, with the most recent change of -$3.03 million (-56.25%) on September 30, 2024.
- Over the past year, VRPX quarterly current liabilities has dropped by -$4.18 million (-63.94%).
- VRPX quarterly current liabilities is now -69.38% below its all-time high of $7.69 million, reached on December 31, 2023.
Performance
VRPX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VRPX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +148.6% | -63.9% |
| 3 y3 years | +110.2% | +30.0% |
| 5 y5 years | +513.5% | +30.0% |
VRPX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +268.5% | -69.4% | +12.8% |
| 5 y | 5-year | at high | +268.5% | -69.4% | +30.0% |
| alltime | all time | at high | +513.5% | -69.4% | +30.0% |
Virpax Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.36 M(-56.3%) |
| Jun 2024 | - | $5.39 M(+24.0%) |
| Mar 2024 | - | $4.34 M(-43.5%) |
| Dec 2023 | $7.69 M(+148.6%) | $7.69 M(+17.8%) |
| Sep 2023 | - | $6.53 M(+79.1%) |
| Jun 2023 | - | $3.65 M(+10.7%) |
| Mar 2023 | - | $3.29 M(+6.4%) |
| Dec 2022 | $3.09 M | $3.09 M(-26.5%) |
| Sep 2022 | - | $4.21 M(+69.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.48 M(+13.6%) |
| Mar 2022 | - | $2.19 M(+4.8%) |
| Dec 2021 | $2.09 M(-43.0%) | $2.09 M(+15.2%) |
| Sep 2021 | - | $1.81 M(-36.0%) |
| Jun 2021 | - | $2.83 M(+7.2%) |
| Mar 2021 | - | $2.64 M(-27.9%) |
| Dec 2020 | $3.66 M(+31.7%) | $3.66 M(+12.0%) |
| Sep 2020 | - | $3.27 M(+17.6%) |
| Dec 2019 | $2.78 M(+121.6%) | $2.78 M |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Virpax Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual current liabilities year-on-year change?
- What is Virpax Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly current liabilities year-on-year change?
What is Virpax Pharmaceuticals annual total current liabilities?
The current annual current liabilities of VRPX is $7.69 M
What is the all time high annual current liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual total current liabilities is $7.69 M
What is Virpax Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, VRPX annual total current liabilities has changed by +$4.60 M (+148.63%)
What is Virpax Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of VRPX is $2.36 M
What is the all time high quarterly current liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly total current liabilities is $7.69 M
What is Virpax Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, VRPX quarterly total current liabilities has changed by -$4.18 M (-63.94%)